Changing patterns of thalassemia worldwide

Area of Science:

• Hematology
• Genetics
• Public Health

Background:

• Thalassemia represents a significant and increasing global public health challenge.
• Hemoglobin E-beta-thalassemia and Hemoglobin H disease are major contributors to the projected rise in thalassemia cases.
• Prevalence of these conditions is growing, even in regions where they were previously uncommon.

Purpose of the Study:

• To highlight the increasing global burden of thalassemia disorders.
• To emphasize the growing significance of Hemoglobin E-beta-thalassemia and Hemoglobin H disease.
• To underscore the need for enhanced diagnostic and care strategies.

Main Methods:

• Review of global epidemiological data on thalassemia.
• Analysis of trends in specific hemoglobinopathies like Hb E-beta-thalassemia and Hb H disease.
• Examination of current screening and management practices.

Main Results:

• An estimated 900,000 births with significant thalassemia disorders are expected in the next 20 years.
• Hemoglobin E-beta-thalassemia is a leading cause, with high incidence in Southeast Asia and growing prevalence in North America.
• Alpha-thalassemia diseases, including Hb H and homozygous alpha-thalassemia, affect over a million people, with increasing detection rates.

Conclusions:

• Prognosis for thalassemia is improving, but requires robust prenatal diagnosis and neonatal screening programs.
• Comprehensive services addressing socioeconomic barriers and access to treatments like Hb F-enhancing agents are essential.
• Public health initiatives, such as California's neonatal screening for Hb H disease, are vital.